JP2774926B2 - Skin protection composition - Google Patents

Skin protection composition

Info

Publication number
JP2774926B2
JP2774926B2 JP5264703A JP26470393A JP2774926B2 JP 2774926 B2 JP2774926 B2 JP 2774926B2 JP 5264703 A JP5264703 A JP 5264703A JP 26470393 A JP26470393 A JP 26470393A JP 2774926 B2 JP2774926 B2 JP 2774926B2
Authority
JP
Japan
Prior art keywords
composition
alkyl group
present
concentration
total weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP5264703A
Other languages
Japanese (ja)
Other versions
JPH0710739A (en
Inventor
クアン・ラン・ニイアン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of JPH0710739A publication Critical patent/JPH0710739A/en
Application granted granted Critical
Publication of JP2774926B2 publication Critical patent/JP2774926B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/05Stick

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Cosmetic or dermopharmaceutic composition. This composition is characterised in that it contains, in a suitable vehicle, an antioxidising system of synergistic action consisting of the combination of a lysine, histidine or arginine lauroylmethionate and of at least one polyphenol chosen from: a) a derivative of 2,5-dihydroxyphenylcarboxylic acid, a homologue or a corresponding salt, b) an ester or amide of caffeic acid, c) a flavonoid or an extract based on flavonoids, d) an extract of rosemary containing diphenols, and their mixtures. The use of the antioxidising system allows good conservation for the compositions containing fatty substances which are sensitive to oxidation.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、塩基性アミノ酸のラウ
ロイルメチオネート(lauroylmethiona
te)(すなわち、N−ラウロイルメテオニンの塩基性
アミノ酸付加塩)と、少なくとも1種のポリフェノール
との組合わせであって相乗効果を有する該組合わせを酸
化防止剤として含有する、皮膚の脂質を酸化から保護す
るための皮膚保護用組成物に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a basic amino acid, lauroylmethionate.
te) (i.e., the N- lauroyl Meteor Nin basic amino acid addition salts), containing said set alignment to have a synergistic effect to a combination of at least one polyphenol as an antioxidant, a lipid skin Protects against oxidation
For protecting the skin .

【0002】[0002]

【従来の技術及び発明が解決しようとする課題】大多数
の化粧料組成物及び皮膚科用組成物などの皮膚を保護す
るための組成物は脂肪相からなり、その油性物質は室温
でもある程度酸化する傾向を有する。この酸化の結果、
前記組成物の諸性質、特に臭気(olfantive
s)が著しく変化し、経時後には前記組成物を使用不能
にする。
To protect the skin, such as BACKGROUND OF THE INVENTION invention is to provide a majority of the cosmetic composition and dermatological compositions
Because of the composition consists of fatty phase, the oily substance has a tendency to Dosan of extent also at room temperature. As a result of this oxidation,
The properties of the composition, especially the odor
s) changes significantly, rendering the composition unusable after a period of time.

【0003】これらの酸化現象に対して前記組成物を保
護する目的で、酸化防止剤として作用する保護剤を配合
することが慣例となっている。
[0003] In order to protect the composition against these oxidation phenomena, it is customary to incorporate a protective agent acting as an antioxidant.

【0004】最も普通に使用される酸化防止性化合物の
中から、アスコルビン酸(これは、特に酸素を直接吸収
することによって作用する)を挙げ得るが、しかしなが
らアスコルビン酸は、脂肪中に極めて溶けにくいという
欠点を有し、その結果として前記組成物を十分に保護す
ることができない。
[0004] Among the most commonly used antioxidant compounds, mention may be made of ascorbic acid, which acts in particular by directly absorbing oxygen, but ascorbic acid is very poorly soluble in fats. As a result, the composition cannot be sufficiently protected.

【0005】アスコルビン酸の難点を克服するために、
最近、種々の酸化防止剤系(systemes antioxydants)
が、特に仏国特許出願第90 11384号(特許第2,666,809
号)明細書において提案されている。該酸化防止剤系は
トコフェロール又はトコフェロール誘導体の少なくとも
1種と、チオール化されていないポリペプチドの少なく
とも1種とからなる。
In order to overcome the difficulties of ascorbic acid,
Recently, various antioxidant systems
In particular, French Patent Application No. 90 11384 (Patent No. 2,666,809)
No.) is proposed in the specification. The antioxidant system comprises at least one tocopherol or tocopherol derivative and at least one non-thiolated polypeptide.

【0006】同様に、仏国特許出願第88 10295号(特許
第2,634,779 号)明細書においては、トコフェロール又
はトコフェロール類混合物、あるいはカフェー酸又はそ
の誘導体類の1種と、錯生成剤の少なくとも1種と、チ
オール化されていないポリペプチドの少なくとも1種と
からなる酸化防止剤系を使用することが提案されてい
る。
Similarly, French Patent Application No. 88 10295 (Patent No. 2,634,779) discloses that tocopherol or a mixture of tocopherols, or one of caffeic acid or a derivative thereof and at least one complexing agent It has been proposed to use an antioxidant system consisting of at least one non-thiolated polypeptide.

【0007】これらの酸化防止剤系は特に著しい相乗効
果を有するが、それにもかかわらずこれらは長期の貯蔵
期間中に保存についての問題を生じる傾向を有する。
[0007] Although these antioxidant systems have a particularly pronounced synergistic effect, they nonetheless tend to cause storage problems during prolonged storage.

【0008】前記の酸化防止剤類が皮膚保護用組成物中
の脂肪類の良好な保存にとって有効であるならば、該組
成物は、ある用途において過酸化物、特に大気汚染物又
は紫外線の作用によって形成される有機過酸化物の有害
な影響を効率的に取り除くことを可能にし得る。
If the antioxidants described above are effective for the good preservation of fats in skin-protecting compositions, the compositions may in certain applications be subject to the action of peroxides, especially air pollutants or ultraviolet light. Can effectively remove the deleterious effects of the organic peroxide formed by the organic peroxide.

【0009】生細胞は、脂質過酸化物に対する種々の生
得の(naturels)手段、特に表皮グルタチオンペルオキシ
ダーゼを有するが、該表皮グルタチオンペルオキシダー
ゼの解毒効力は紫外線暴露の影響下においては大きく低
下する。
Living cells have a variety of natural means for lipid peroxides, especially epidermal glutathione peroxidase, but the detoxifying efficacy of the epidermal glutathione peroxidase is greatly reduced under the influence of UV exposure.

【0010】従って、取返しのつかない(irreversible)
細胞損傷を生じ得る酸化現象の原因であるフリーラジカ
ル(遊離基)の形成を防止できる酸化防止剤を有し得る
ことが重要である。
[0010] Therefore, it is irreversible
It is important to have an antioxidant that can prevent the formation of free radicals (free radicals) that are responsible for the oxidative phenomena that can cause cell damage.

【0011】[0011]

【課題を解決するための手段、作用及び効果】多数の物
質について種々の研究を行った後に、容易に酸化されや
すい脂肪(corps gras)を含有する皮膚保護
用組成物を良好に保存し得ること、それに加えて塩基性
アミノ酸のラウロイルメチオネートと、少なくとも1種
のポリフェノールとからなる相乗効果をもつ酸化防止剤
系を使用することによって皮膚脂質を効率的に保護する
ことの両方を可能にしることが、本発明者らによって
意外にも知見された。
SUMMARY OF THE INVENTION After conducting various studies on a number of substances, a skin-protecting composition containing easily oxidizable fats (corps glas) was successfully improved. Both storable and, in addition, efficiently protecting skin lipids by using a synergistic antioxidant system consisting of the basic amino acid lauroyl methionate and at least one polyphenol. allowing the resulting Rukoto is surprisingly been found by the present inventors.

【0012】従って、本発明の要旨によれば、リシン、
ヒスチジン又はアルギニンのラウロイルメチオネート
と、下記のポリフェノールすなわち a)(2,5−ジヒドロキシフェニル)カルボン酸誘導
体、その同族体又は対応する塩、 b)カフェー酸エステル又はカフェー酸アミド、 c)フラボノイド、又はフラボノイド類含有抽出物、 d)ジフェノール類を含有するマンネンロウ(roma
rin)抽出物、及びこれらの混合物から選択されるポ
リフェノールの少なくとも1種との組合せからなる酸化
防止剤系であって相乗効果を有する該酸化防止剤系を適
当なビヒクル中に含有してなることを特徴とする、皮膚
の脂質を酸化から保護するための皮膚保護用組成物が提
供される。
Therefore, according to the gist of the present invention, ricin,
Lauroyl methionate of histidine or arginine and the following polyphenols: a) (2,5-dihydroxyphenyl) carboxylic acid derivative, homologue or corresponding salt thereof; b) caffeic acid ester or caffeic acid amide; c) flavonoid; Or an extract containing flavonoids, d) mannen wax containing diphenols (roma
rin) extract, and that Do contained in a suitable vehicle the antioxidant system having a synergistic effect an antioxidant system comprising a combination of at least one polyphenol chosen from mixtures thereof Characterized by the fact that the skin
Provided is a skin-protecting composition for protecting lipids from oxidation .

【0013】前記ラウロイルメチオネート類の中で、本
発明に従って使用することが特に好ましいものは、Giva
udan Lavirotte社から販売されているL-リシン・ラウロ
イルメチオネート(MW=477.7)である。
Among the aforementioned lauroyl methionates, particularly preferred for use according to the invention are Giva
L-lysine lauroyl methionate (MW = 477.7) sold by udan Lavirotte.

【0014】前記 (2,5-ジヒドロキシフェニル)カルボ
ン酸誘導体、その同族体及びその塩は公知の化合物であ
り、これらは特に仏国特許出願第78.24174号(特許第2,
400,358 号)及び同第78.24175号(特許第2,400,359
号)明細書に記載されている。
The above (2,5-dihydroxyphenyl) carboxylic acid derivatives, homologues and salts thereof are known compounds, and they are particularly known from French Patent Application No. 78.24174 (Patent No. 2,
No. 400,358) and No. 78.24175 (Patent No. 2,400,359)
No.) is described in the specification.

【0015】これら (2,5-ジヒドロキシフェニル)カル
ボン酸誘導体は、次の一般式(I): 〔式中、R1 は基OR4 、OH又は-N(r')(r'') を表わし、
4 は直鎖又は分岐鎖(C1 〜C20)アルキル基、直鎖
又は分岐鎖(C〜C20)アルケニル基、あるいは1個
又は多数の水酸基又はアルコキシ基で置換された(C1
〜C20)アルキル基を表わし、r'及びr'' は同一である
か又は異なるものであって、水素原子、(C1 〜C20
アルキル基、(C2 〜C)ヒドロキシアルキル基又は
(C3 〜C)ポリヒドロキシアルキル基を表わすか、
あるいはr'及びr'' は一緒になって窒素原子と共に複素
環を形成し、mは1又は2であり、(i) mが1である場
合には、基R2 及びR3 のうちの少なくとも一方は直鎖
又は分岐鎖(C1 〜C)アルキル基を表わし、他方は
場合によっては水素原子を表わし、(ii)mが2である場
合には、R2 及びR3 は同一であるか又は異なるもので
あって、水素原子あるいは直鎖又は分岐鎖(C1
)アルキル基を表わす〕で示し得る。
These (2,5-dihydroxyphenyl) carboxylic acid derivatives have the following general formula (I): Wherein R 1 represents a group OR 4 , OH or —N (r ′) (r ″),
R 4 is substituted with a linear or branched (C 1 -C 20 ) alkyl group, a linear or branched (C 2 -C 20 ) alkenyl group, or one or more hydroxyl or alkoxy groups (C 1
CC 20 ) alkyl, wherein r ′ and r ″ are the same or different and are a hydrogen atom, (C 1 -C 20 )
Alkyl group, or represents (C 2 ~C 6) hydroxyalkyl group or a (C 3 ~C 6) polyhydroxyalkyl group,
Alternatively, r ′ and r ″ together form a heterocycle with the nitrogen atom, m is 1 or 2, and (i) when m is 1, of the radicals R 2 and R 3 At least one of them represents a linear or branched (C 1 -C 4 ) alkyl group, the other optionally represents a hydrogen atom, and (ii) when m is 2, R 2 and R 3 are the same. A hydrogen atom or a linear or branched chain (C 1 to
C 4 ) represents an alkyl group].

【0016】特に好ましい、一般式(I) で示される化合
物の中から、特に2,5-ジヒドロキシ-4- メチル- フェニ
ル酢酸メチルを挙げることができる。
Among the particularly preferred compounds represented by the general formula (I), methyl 2,5-dihydroxy-4-methyl-phenylacetate can be particularly mentioned.

【0017】前記カフェー酸エステルの中から、特に次
の式(II): 〔式中、Zは(C1 〜C)アルキル基又はフィトール
残基を表わす〕で示される化合物を挙げることができ
る。
Among the above-mentioned caffeic acid esters, in particular, the following formula (II): [Wherein, Z represents a (C 1 -C 8 ) alkyl group or a phytol residue].

【0018】前記カフェー酸アミドの中から、特に次の
式(III): 〔式中、Z´は(C1 〜C)アルキル基、特に(C6
〜C)アルキル基を表わす〕で示される化合物を挙げ
ることができる。
Among the above-mentioned caffeic acid amides, in particular, the following formula (III): [Wherein, Z ′ is a (C 1 -C 8 ) alkyl group, particularly (C 6
To C 8 ) alkyl group].

【0019】前記の式(II)又は(III) で示される化合物
は公知であり、公知の方法に従って調製し得る。
The compound represented by the above formula (II) or (III) is known and can be prepared according to a known method.

【0020】前記フラボノイドの中から、下記の2つの
一般式、すなわち次の一般式(IV): 〔式中、A″、B″、C″及びD″は、互いに独立して
それぞれH又はOHを表わし;E″はH、OH又はOX'(但
し、X´は下記の基: を表わす)を表わし;F″、G″及びJ″は互いに独立
してそれぞれH又はOHを表わし;且つX1 は -CH2 - 、
-CO-又は-CHOH-を表わす:但し、基A″〜G″のうちの
少なくとも2つ又はJ″はOHを表わすこと、あるいは基
E″がOX' を表わすことを条件とする〕、及び次の一般
式(V): 〔式中、A´、C´及びD´は互いに独立してそれぞれ
H、OH又は OCH3 を表わし;E´はH、OH又はOR'(但
し、R´は式R'OHで示される糖の残基を表わす)を表わ
し;B´、F´、G´及びJ´は互いに独立してそれぞ
れH、OH、 OCH3 又は-OCH−CH-OH を表わす:但
し、基A´〜G´のうちの少なくとも2つ又はJ´はOH
を表わすことを条件とする〕に対応するフラボノイドを
挙げることができる。
Among the flavonoids, the following two general formulas, ie, the following general formula (IV): Wherein A ″, B ″, C ″ and D ″ each independently represent H or OH; E ″ represents H, OH or OX ′ (where X ′ represents the following group: F ″, G ″ and J ″ each independently represent H or OH; and X 1 represents —CH 2 —,
-CO- or -CHOH-, provided that at least two of the radicals A "to G" or J "represent OH or that the radical E" represents OX '], and The following general formula (V): Wherein A ′, C ′ and D ′ independently represent H, OH or OCH 3 ; E ′ is H, OH or OR ′ (where R ′ is a sugar represented by the formula R′OH B ′, F ′, G ′ and J ′ each independently represent H, OH, OCH 3 or —OCH 2 —CH 2 —OH, provided that the groups A ′ to At least two of G 'or J' are OH
Flavonoids].

【0021】前記の糖R'OHの中から、ルチノースを挙げ
ることができる。
Among the above-mentioned sugars R'OH, rutinose can be mentioned.

【0022】上記の式(IV)又は式(V) で示される化合物
は公知である。これらの化合物は特に、Harborne J.B.,
Mabry T.J., Helga Mabryの著作“The Flavonoids(フ
ラボノイド)”1975年発行、第1〜45頁に記載の方法に
従って製造し得る。
The compound represented by the above formula (IV) or (V) is known. These compounds are, inter alia, Harborne JB,
Mabry TJ, Helga Mabry, "The Flavonoids", published in 1975, pages 1-45.

【0023】本発明に従って使用し得る上記フラボノイ
ドの中から、特にタキシホリン、カテキン、エピカテキ
ン、エリオジクチオール、ナリンゲニン、ルチン、トロ
キセルチン(troxerutin)、クリシン、タンゲレチン(tan
geretine) 、ルテオリン、エピガロカテキン、エピガロ
カテキンガレート、クェルセチン、フィゼチン、ケンフ
ェロール、ガランギン、ガロカテキン及びエピカテキン
ガレートが挙げられる。
Among the above flavonoids which can be used according to the invention, in particular taxifolin, catechin, epicatechin, eriodictyol, naringenin, rutin, troxerutin, chrysin, tangeretin (tan)
geretine), luteolin, epigallocatechin, epigallocatechin gallate, quercetin, fizetin, kaempferol, galangin, gallocatechin and epicatechin gallate.

【0024】かかる化合物は、特にNikko 社から“Sunp
henon ”という名称で販売されている緑茶抽出物中に存
在する。
Such compounds are particularly described by Nikko in "Sunp
Henon is present in the green tea extract sold under the name.

【0025】本発明に従って使用し得るマンネンロウ抽
出物は、カルノシン酸(l'acide carnosique)及びカルノ
ゾル(carnosol)を含有することを特徴とし、該抽出物
は、例えばマンネンロウから抽出し次いで蒸留する(Ch
angらの論文、JOSC,第61巻第6号、1984年6月発行)
か、又は欧州特許出願公開第307,626号明細書に記載の
ようにして、臭気物質を除去する目的で、極性溶媒例え
ばエタノールで抽出し次いで非極性溶媒例えば例えばヘ
キサンで抽出するか、いずれかにより抽出し得る。
The extract of mannen wax which can be used according to the invention is characterized in that it contains l'acide carnosique and carnosol, which extract is extracted, for example, from mannen wax and then distilled (Ch
ang et al., JOSC, Vol. 61, No. 6, issued June 1984)
Or Europe as described in Patent Application EP 307,626, for the purpose of removing odorous substances, or by extraction with a polar solvent such as ethanol and then extracted with a nonpolar solvent such as hexane, extracted with either I can do it.

【0026】カルノシン酸及びカルノゾールは、下記の
式に対応するものである。
Carnosic acid and carnosol correspond to the following formula:

【0027】本発明の皮膚保護用組成物において、前記
のリシン、ヒスチジン又はアルギニンのラウロイルメチ
オネートは、一般的に該組成物の重量全体に対して0.
02%〜5%の濃度で存在させる。
In the skin-protecting composition of the present invention, the lysine, histidine or arginine lauroyl methionate is generally used in an amount of 0.5% based on the total weight of the composition.
It is present at a concentration between 02% and 5%.

【0028】前記のポリフェノールは、前記組成物の重
量全体に対して0.005 〜5重量%の割合で存在させる。
塩基性アミノ酸・ラウロイルメチオネートと該ポリフェ
ノールの比率は、一般的に20/80〜90/10である。
The polyphenol is present in a proportion of 0.005 to 5% by weight based on the total weight of the composition.
The ratio of the basic amino acid lauroyl methionate to the polyphenol is generally between 20/80 and 90/10.

【0029】前記ポリフェノールが前記の一般式(I) で
示される(2,5- ジヒドロキシフェニル)カルボン酸誘導
体である場合には、該誘導体は前記組成物の重量全体に
対して0.05〜1重量%の濃度で存在させるのが好まし
い。
When the polyphenol is a (2,5-dihydroxyphenyl) carboxylic acid derivative represented by the general formula (I), the derivative is present in an amount of 0.05 to 1% by weight based on the total weight of the composition. It is preferred to be present at a concentration of

【0030】前記ポリフェノールがカフェー酸エステル
又はカフェー酸アミドである場合には、その濃度は前記
組成物の重量全体に対して0.05〜2重量%であるのが好
ましい。
When the polyphenol is caffeic acid ester or caffeic amide, its concentration is preferably 0.05 to 2% by weight based on the total weight of the composition.

【0031】さらにまた、フラボノイド、又はフラボノ
イド類含有抽出物を使用する場合には、これらは一般的
に前記組成物の重量全体に対して0.1 〜5重量%の濃度
で存在させる。
Furthermore, if flavonoids or extracts containing flavonoids are used, they are generally present in a concentration of from 0.1 to 5% by weight, based on the total weight of the composition.

【0032】同様に、カルノシン酸及びカルノゾルを含
有するマンネンロウ抽出物を使用する場合には、該マン
ネンロウ抽出物は一般的に前記組成物の重量全体に対し
て0.1 〜5重量%の濃度で存在させる。
Similarly, if a mannen wax extract containing carnosic acid and carnosol is used, the mannen wax extract is generally present in a concentration of 0.1 to 5% by weight, based on the total weight of the composition. .

【0033】本発明の組成物は非常に変化に富んだ性質
のものであリ得るが、特に、酸化を受けやすい脂肪類の
少なくとも1種を種々の割合で、好ましくは1〜99重量
%の割合で含有する組成物であるのが特に好ましい。
The compositions according to the invention can be of a very variable nature, in particular at least one fat which is susceptible to oxidation, in various proportions, preferably 1 to 99% by weight. It is particularly preferred that the composition contains a proportion.

【0034】本発明の組成物中に存在する脂肪類は、例
えば動物起源の脂肪例えばセチン(鯨ロウ)、蜜ロウ、
ラノリン、ペルヒドロスクワラン、海ガメの油など;
油、脂肪又はワックスの形態の植物脂肪、例えばアーモ
ンド油、アボガド油、オリーブ油、胡麻油又はマカデミ
ア油;水添されていてもよいヤシ油又はパーム核油、コ
コアバター、カルナウバロウあるいはモンタンロウ;並
びにグリセロール又はグリコールのエステル類及び/又
はエーテル類からなる合成油、例えば仏国特許出願第7
5.24656号(特許第2,281,916 号)、同第75.24657号
(特許第2,281,743号)及び同第75.24658号(特許第2,2
81,744 号)明細書に記載のものである。
The fats present in the compositions according to the invention are, for example, fats of animal origin, such as cetine (whale wax), beeswax,
Lanolin, perhydrosqualane, sea turtle oil, etc .;
Vegetable fats in the form of oils, fats or waxes, such as almond oil, avocado oil, olive oil, sesame oil or macadamia oil; optionally hydrogenated coconut or palm kernel oil, cocoa butter, carnauba wax or montan wax; and glycerol or glycol Synthetic oils comprising esters and / or ethers, such as French Patent Application No. 7
No. 5.24656 (Patent No. 2,281,916), No. 75.24657 (Patent No. 2,281,743) and No. 75.24658 (Patent No. 2,2
No. 81,744).

【0035】本発明の皮膚保護用組成物は、多少の酸化
を受けやすい脂肪のほかに酸化を受けやすい化合物例え
ばビタミンF又はβ−カロチンも含有し得る。
The skin-protecting composition of the present invention may also contain oxidizable compounds such as vitamin F or β-carotene in addition to some oxidizable fats.

【0036】本発明の皮膚保護用組成物は、特に油性溶
液、油中水型乳濁液、水中油型乳濁液、場合によっては
無水固体物質、ローション、微細分散物又は小胞分散物
の形態で提供される。前記小胞を構成する脂質はイオン
型又は非イオン型のものであるか、あるいはこれらの混
合物であり得る。また、本発明の皮膚保護用組成物は、
スキンケア用乳液、クリーム〔フェース(顔面)クリー
ム、ハンドクリーム、ボディークリーム、日焼け止めク
リーム、メーキャップ落とし用クリーム、ファンデーシ
ョンクリーム〕、液体ファンデーション、メーキャップ
落とし用乳液、浴用油、口紅、アイシャドー、デオドラ
ントスチックなどの形態で提供し得る。
The skin-protecting compositions according to the invention can be used, in particular, in the form of oily solutions, water-in-oil emulsions, oil-in-water emulsions, optionally anhydrous solid substances, lotions, fine dispersions or vesicle dispersions. Provided in form. The lipid constituting the vesicle may be of an ionic or non-ionic type, or a mixture thereof. Further, the composition for skin protection of the present invention,
Emulsions for skin care, creams [face (face) cream, hand cream, body cream, sun cream, makeup remover cream, foundation cream], liquid foundation, makeup remover, bath oil, lipstick, eye shadow, deodorant stick, etc. It can be provided in the form of

【0037】局部施用には、本発明の皮膚保護用組成物
は、例えば膏薬、クリーム、乳液、軟膏又は油性溶液中
に該組成物を存在させることを可能にさせるのに必要な
成分と、ビヒクルとを含有する。
For topical application, the skin-protecting composition of the invention comprises, for example, the ingredients necessary to enable the composition to be present in a salve, cream, emulsion, ointment or oily solution, together with a vehicle. And

【0038】好ましい態様によれば、本発明の皮膚保護
用組成物は、局部的に施用することを意図した形態で、
特に皮膚の脂質を酸化から保護することを意図したクリ
ームの形態で提供される。
According to a preferred embodiment, the skin-protecting composition according to the invention is in a form intended for topical application,
In particular, it is provided in the form of a cream intended to protect skin lipids from oxidation.

【0039】本発明の皮膚保護用組成物は、種々の標準
的な添加剤例えば界面活性剤、染料、香料、アストリン
ゼント物質、紫外線吸収性物質及び有機溶剤を追加成分
としてさらに含有し得る。
The skin-protecting composition of the present invention may further contain various standard additives such as surfactants, dyes, fragrances, astringent substances, ultraviolet light absorbing substances and organic solvents as additional components.

【0040】本発明の皮膚保護用組成物は慣用の方法に
従って製造される。
The skin-protecting composition of the present invention is produced according to a conventional method.

【0041】[0041]

【実施例】本発明の皮膚保護用組成物を以下の実施例に
より説明する。実施例1:モイスチャアクリーム % − リシン・ラウロイルメチオネート 1.15 − 2.5−ジヒドロキシ−4−メチル−フェニル酢酸メチル 1.0 − Mg・ラノレート(lanolate) 3.0 − ラノリンアルコール 5.0 − パラフィン油 27.0 − パラフィンゼリー 15.0 − p−ヒドロキシ安息香酸メチル 0.2 − p−ヒドロキシ安息香酸プロピル 0.1 − 脱イオン水 全量を100%にするのに必要な量
Examples The skin-protecting composition of the present invention is described by the following examples. Example 1: Moisture cream %-Lysine lauroyl methionate 1.15-2.5-Methyl dihydroxy-4-methyl-phenylacetate 1.0-Mg lanolate 3.0-Lanolin alcohol 5. 0-paraffin oil 27.0-paraffin jelly 15.0-methyl p-hydroxybenzoate 0.2-propyl p-hydroxybenzoate 0.1-deionized water The amount required to bring the total amount to 100%.

【0042】実施例2:保護クリーム % − リシン・ラウロイルメチオネート 1.3 − クェルセチン 0.5 − マンネンロウ抽出物 1.0 − 自己乳化性グリセリルステアレート 3.0 − セチルアルコール 0.5 − ステアリルアルコール 0.5 − パラフィン油 12.0 − 胡麻油 10.0 − ステアリン酸 3.0 − p-ヒドロキシ安息香酸メチル 0.2 − p-ヒドロキシ安息香酸プロピル 0.1 − 香料 0.3 − 脱イオン水 全量を100%にするのに必要な量 Example 2: Protective cream %-Lysine lauroyl methionate 1.3-Quercetin 0.5-Mannen wax extract 1.0-Self-emulsifying glyceryl stearate 3.0-Cetyl alcohol 0.5-Stearyl alcohol 0.5-Paraffin oil 12.0-Sesame oil 10.0- Stearic acid 3.0-Methyl p-hydroxybenzoate 0.2-Propyl p-hydroxybenzoate 0.1-Fragrance 0.3-Deionized water Required to bring the total amount to 100%

【0043】実施例3:保護用モイスチャアクリーム % − リシン・ラウロイルメチオネート 2.3 − 緑茶からのフラボノイド抽出物 (Jan Dekker Inc.社の“Sunphenon ”) 1.0 − グリセリルステアレート 3.0 − ステアリルアルコール 0.5 − ステアリン酸 2.0 − ペルヒドロスクワラン 12.0 − 揮発性シリコーン油 5.0 − p-ヒドロキシ安息香酸メチル 0.2 − p-ヒドロキシ安息香酸プロピル 0.1 − 香料 0.3 − 脱イオン水 全量を100%にするのに必要な量 Example 3: Moisture cream for protection %-Lysine lauroyl methionate 2.3-Flavonoid extract from green tea ("Sunphenon" from Jan Dekker Inc.) 1.0-Glyceryl stearate 3.0-Stearyl alcohol 0.5- Stearic acid 2.0-Perhydrosqualane 12.0-Volatile silicone oil 5.0-Methyl p-hydroxybenzoate 0.2-Propyl p-hydroxybenzoate 0.1-Fragrance 0.3-Deionized water Amount required to bring the total to 100%

【0044】実施例4:手用の保護クリーム % − リシン・ラウロイルメチオネート 0.345 − カフェー酸メチル 0.4 − ルチン 0.5 − エチレンオキシド20モルでポリオキシエチレン化した ソルビタンモノステアレート 2.0 − セチルアルコール 1.0 − ミリスチン酸イソプロピル 3.0 − パラフィン油 7.0 − 揮発性シリコーン油 7.0 − p-ヒドロキシ安息香酸メチル 0.2 − p-ヒドロキシ安息香酸プロピル 0.1 − 脱イオン水 全量を100%にするのに必要な量 Example 4: Protective cream % for hands- Lysine lauroyl methionate 0.345-Methyl caffeate 0.4-Rutin 0.5-Sorbitan monostearate 2.0 polyoxyethylenated with 20 moles of ethylene oxide 2.0-Cetyl alcohol 1.0-Myristin Isopropyl acid 3.0-Paraffin oil 7.0-Volatile silicone oil 7.0-Methyl p-hydroxybenzoate 0.2-Propyl p-hydroxybenzoate 0.1-Deionized water Amount required to bring the total amount to 100%

【0045】実施例5:小胞分散物 % − リシン・ラウロイルメチオネート 0.23 − 2,5-ジヒドロキシ-4- メチル- フェニル酢酸メチル 0.05 − 水素化大豆レシチン 1.8 − コレステロール 0.9 − コラーゲン性パルミトイルリパシド(lipacide palmitoyl) 0.3 − グリセロール 0.3 − マカダミア油 15.0 − 揮発性シリコーン油 10.0 − Gddorich社から“Carbopol 940”という名称で販売 されているカルボキシビニル重合体 0.6 − p-ヒドロキシ安息香酸メチル 0.2 − トリエタノールアミン pH=6にするのに必要な量 − 脱イオン水 全量を100%にするのに必要な量 Example 5: Vesicle dispersion %-Lysine lauroyl methionate 0.23-Methyl 2,5-dihydroxy-4-methyl-phenylacetate 0.05-Hydrogenated soybean lecithin 1.8-Cholesterol 0.9-Collagen palmitoyl lipased (lipacide palmitoyl) 0.3-Glycerol 0.3-Macadamia oil 15.0-Volatile silicone oil 10.0-Carboxyvinyl polymer sold by Gddorich under the name "Carbopol 940" 0.6-Methyl p-hydroxybenzoate 0.2-Triethanolamine Amount needed to reach pH = 6-Deionized water Amount needed to bring the total volume to 100%

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI A61K 31/22 A61K 31/22 31/35 31/35 35/78 35/78 C C09K 15/08 C09K 15/08 15/20 15/20 15/34 15/34 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 6 Identification code FI A61K 31/22 A61K 31/22 31/35 31/35 35/78 35/78 C C09K 15/08 C09K 15/08 15/20 15/20 15/34 15/34

Claims (16)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 リシン、ヒスチジン又はアルギニンのラ
ウロイルメチオネートと、下記のポリフェノールすなわ
ち a)(2,5−ジヒドロキシフェニル)カルボン酸誘導
体、その同族体又は対応する塩、 b)カフェー酸エステル又はカフェー酸アミド、 c)フラボノイド、又はフラボノイド類含有抽出物、 d)ジフェノール類を含有するマンネンロウ抽出物、及
びこれらの混合物から選択されるポリフェノールの少な
くとも1種との組合せからなる酸化防止剤系であって相
乗効果を有する該酸化防止剤系を適当なビヒクル中に含
してなることを特徴とする、皮膚の脂質を酸化から保
護するための皮膚保護用組成物。
1. Lauroyl methionate of lysine, histidine or arginine and the following polyphenols: a) (2,5-dihydroxyphenyl) carboxylic acid derivative, homologue or corresponding salt, b) caffeic acid ester or caffeine An antioxidant system comprising a combination with at least one polyphenol selected from acid amide, c) a flavonoid or an extract containing flavonoids, d) a mannen wax extract containing diphenols, and a mixture thereof. coercive characterized by containing a suitable vehicle in antioxidant system having a synergistic effect Te, the skin lipids from oxidation
A composition for protecting the skin .
【請求項2】 前記酸化防止剤系がリシン・ラウロイル
メチオネートを含有するものである請求項記載の組成
物。
2. A composition of claim 1 wherein said antioxidant system is one that contains a lysine Lauro Irume isethionate.
【請求項3】 前記(2.5−ジヒドロキシフェニル)
カルボン酸誘導体が次の 〔式中、Rは基OR、OH又は−N(r′)
(r″)を表わし、 Rは直鎖又は分岐鎖(C−C20)アルキル基、直
鎖又は分岐鎖(C〜C20)アルケニル基、あるいは
1個又は多数の水酸基又はアルコキシ基で置換された
(C−C20)アルキル基を表わし、 r′及びr″は同一であるか又は異なるものであって、
水素原子、(C〜C20)アルキル基、(C
)ヒドロキシアルキル基又は(C〜C)ポリヒ
ドロキシアルキル基を表わすか、あるいはr′及びr″
は一緒になって窒素原子と共に複素環を形成し、 mは1又は2であり、 (i)mが1である場合には、基R及びRのうちの
少なくとも一方は直鎖又は分岐鎖(C〜C)アルキ
ル基を表わし、他方は場合によっては水素原子を表わ
し、 (ii)mが2である場合には、R及びRは同一で
あるか又は異なるものであって、水素原子あるいは直鎖
又は分岐鎖(C〜C)アルキル基を表わす〕に対応
するものである請求項記載の組成物。
3. The (2.5-dihydroxyphenyl)
The carboxylic acid derivative is Wherein R 1 is a group OR 4 , OH or —N (r ′)
R 4 represents a linear or branched (C 1 -C 20 ) alkyl group, a linear or branched (C 2 -C 20 ) alkenyl group, or one or more hydroxyl or alkoxy groups Represents a (C 1 -C 20 ) alkyl group substituted by: wherein r ′ and r ″ are the same or different,
Hydrogen atom, (C 1 -C 20 ) alkyl group, (C 2-
Represents a C 6 ) hydroxyalkyl group or a (C 3 -C 6 ) polyhydroxyalkyl group, or r ′ and r ″
Together form a heterocycle with the nitrogen atom, m is 1 or 2, and (i) when m is 1, at least one of the radicals R 2 and R 3 is linear or branched A chain (C 1 -C 4 ) alkyl group, the other optionally a hydrogen atom, and (ii) when m is 2, R 2 and R 3 are the same or different. Te, hydrogen atom or a linear or branched (C 1 -C 4) the composition of claim 1, wherein corresponds to an alkyl group].
【請求項4】 前記(2,5−ジヒドロキシフェニル)
カルボン酸誘導体が2,5−ジヒドロキシ−4−メチル
ーフェニル酢酸メチルである請求項1又は3に記載の組
成物。
4. The (2,5-dihydroxyphenyl)
A composition according to claim 1 or 3 carboxylic acid derivative is 2,5-dihydroxy-4-methylcyclohexyl phenylacetate.
【請求項5】 前記カフェー酸エステルが次の式: 〔式中、Zは(C−C)アルキル基又はフィトール
残基を表わす〕に対応するものである請求項記載の組
成物。
5. The method of claim 1, wherein the caffeic acid ester has the formula: [Wherein, Z is (C 1 -C 8) alkyl group or phytol residue] The composition of claim 1, wherein corresponds to.
【請求項6】 前記カフェー酸アミドが次の式: 〔式中、Z′は(C〜C)アルキル基を表わす〕に
対応するものである請求項記載の組成物。
6. The method of claim 1, wherein the caffeamide is of the formula: Wherein, Z 'is (C 1 -C 8) alkyl group] The composition of claim 1, wherein corresponds to.
【請求項7】 前記フラボノイドが下記の2つの式のう
ちの1つ、すなわち次の式(IV): 〔式中、A″、B″、C″及びD″は、互いに独立して
それぞれH又はOHを表わし; E″はH、OH又はOX′(但し、X′は下記の基: を表わす)を表わし; F″、G″及びJ″は互いに独立してそれぞれH又はO
Hを表わし;且つXは−CH−、−CO−又は−C
HOH−を表わす:但し、基A″〜G″のうちの少なく
とも2つ又はJ″はOHを表わすこと、あるいは基E″
がOX′を表わすことを条件とする〕、及び次の式
(V): 〔式中、A′、C′及びD′は互いに独立してそれぞれ
H、OH又はOCHを表わし; E′はH、OH又はOR′(但し、R′は式R′OHで
示される糖の残基を表わす)を表わし; B′、F′、G′及びJ′は互いに独立してそれぞれ
H、OH、OCH又は−OCH−CH−OHを表
わす:但し、基A′〜G′のうちの少なくとも2つ又は
J′はOHを表わすことを条件とする〕のうちの1つに
対応するものである請求項記載の組成物。
7. The method according to claim 1, wherein the flavonoid is one of the following two formulas: Wherein A ″, B ″, C ″ and D ″ independently represent H or OH, respectively; E ″ is H, OH or OX ′ (where X ′ is the following group: F ", G" and J "are each independently H or O
H represents X; and X 1 represents —CH 2 —, —CO— or —C
Represents HOH—, provided that at least two of the radicals A ″ to G ″ or J ″ represent OH, or the radical E ″
Represents OX ′], and the following formula (V): Wherein, A ', C' and D 'represent each H, OH or OCH 3 independently of one another; E' is H, OH or OR '(where, R' is a sugar of formula R'OH B ′, F ′, G ′ and J ′ each independently represent H, OH, OCH 3 or —OCH 2 —CH 2 —OH, provided that the groups A ′ to 'at least two of or J' G composition of claim 1, wherein which corresponds to one of a condition that represents OH].
【請求項8】 前記のリシン、ヒスチジン又はアルギニ
ンのラウロイルメチオネートが前記組成物の重量全体に
対して0.02%〜5%の濃度で存在する請求項記載
の組成物。
Wherein said lysine, histidine or arginine Lauro Irume composition Motomeko 1 wherein that isethionate is be present in a concentration of 0.02% to 5% relative to the total weight of said composition.
【請求項9】 前記ポリフェノールが前記組成物の重量
全体に対して0.005〜5重量%の濃度で存在する請
求項記載の組成物。
9. <br/> Motomeko 1 composition, wherein the polyphenol is you present in a concentration of 0.005 to 5% by weight relative to the total weight of said composition.
【請求項10】 前記(2,5−ジヒドロキシフェニ
ル)カルボン酸誘導体が前記組成物の重量全体に対して
0.05〜1重量%の濃度で存在する請求項1、3又は
に記載の組成物。
Wherein said claim 1 (2,5-dihydroxyphenyl) carboxylic acid derivative is present at a concentration of 0.05 to 1% by weight relative to the total weight of the composition, 3 or
5. The composition according to 4 .
【請求項11】 前記カフェー酸エステル及び/又はカ
フェー酸アミドが前記組成物の重量全体に対して0.0
5〜2重量%の濃度で存在する請求項1、5又は6に記
載の組成物。
11. The method according to claim 11, wherein the caffeic acid ester and / or caffeic acid amide is present in an amount of 0.0
The composition according to claim 1, 5 or 6 , which is present in a concentration of from 5 to 2% by weight.
【請求項12】 前記のフラボノイド、又はフラボノイ
ド類含有抽出物が前記組成物の重量全体に対して0.1
〜5重量%の濃度で存在する請求項記載の組成物。
12. The flavonoid or flavonoid-containing extract may be contained in an amount of 0.1% to the total weight of the composition.
The composition of claim 1 which is present in a concentration of 5 wt%.
【請求項13】 前記マンネンロウ抽出物がカルノシン
酸(l’acidcarnosique)及びカルノゾ
ル(carnosol)を含有するものであり且つ前記
組成物の重量全体に対して0.1〜5重量%の濃度で存
在する請求項記載の組成物。
13. The extract of mannen wax containing l'acid carnosique and carnosol and present at a concentration of 0.1 to 5% by weight based on the total weight of the composition. The composition of claim 1 .
【請求項14】 酸化を受けやすい脂肪の少なくとも1
種を、前記組成物の重量全体に対して1〜99重量%の
割合で含有する請求項1〜13のいずれか1項に記載の
組成物。
14. At least one of the fats susceptible to oxidation
Seeds, composition according to any one of Motomeko 1-13 you in a proportion of 1 to 99% by weight relative to the total weight of said composition.
【請求項15】 ビタミンF又はβ−カロチンから選択
される酸化を受けやすい化合物の少なくとも1種を含有
る請求項1〜14のいずれか1項に記載の組成物。
15. Vitamin F or β- composition according to any one of Motomeko 1-14 you containing <br/> at least one oxidizing susceptible compound selected from carotene.
【請求項16】 界面活性剤、染料、香料、アストリン
ゼント物質、紫外線吸収性物質及び有機溶剤から選択さ
れる種々の添加剤を追加成分としてさらに含有する請
1〜15のいずれか1項に記載の組成物。
16. surfactants, dyes, perfumes, astringents material, any one of Motomeko 1-15 that further to contain various additives selected from UV absorbing agent and an organic solvent as an additional component A composition according to claim 1.
JP5264703A 1992-10-22 1993-10-22 Skin protection composition Expired - Fee Related JP2774926B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9212654A FR2697159B1 (en) 1992-10-22 1992-10-22 Cosmetic or dermo-pharmaceutical composition containing in combination a lauroylmethionate of a basic amino acid and at least one polyphenol.
FR9212654 1992-10-22

Publications (2)

Publication Number Publication Date
JPH0710739A JPH0710739A (en) 1995-01-13
JP2774926B2 true JP2774926B2 (en) 1998-07-09

Family

ID=9434788

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5264703A Expired - Fee Related JP2774926B2 (en) 1992-10-22 1993-10-22 Skin protection composition

Country Status (8)

Country Link
US (2) US5431912A (en)
EP (1) EP0595694B1 (en)
JP (1) JP2774926B2 (en)
AT (1) ATE141500T1 (en)
CA (1) CA2108804C (en)
DE (1) DE69304172T2 (en)
ES (1) ES2093385T3 (en)
FR (1) FR2697159B1 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358752A (en) * 1993-02-23 1994-10-25 Norac Technologies Inc. Skin care composition
DE4444238A1 (en) 1994-12-13 1996-06-20 Beiersdorf Ag Cosmetic or dermatological drug combinations of cinnamic acid derivatives and flavone glycosides
US7968140B2 (en) * 1997-09-08 2011-06-28 Mars, Incorporated Chocolates and chocolate liquor having an enhanced polyphenol content
US5665367A (en) * 1996-09-27 1997-09-09 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin care compositions containing naringenin and/or quercetin and a retinoid
JP3625976B2 (en) * 1997-01-30 2005-03-02 高砂香料工業株式会社 Deodorant composition
FR2765109B1 (en) * 1997-06-25 2001-02-09 Seppic Sa COMPOSITION COMPRISING A LIPOAMINOACID AND THE CONSTITUENTS OF A TANNIN-RICH PLANT EXTRACT AND USE IN COSMETICS
DE19739044A1 (en) * 1997-09-05 1999-03-11 Beiersdorf Ag Use of di:hydro-robinetin as antioxidant and/or radical scavenger
DE19739349A1 (en) * 1997-09-09 1999-03-11 Beiersdorf Ag Use of troxerutin as antioxidant and/or radical scavenger
DE19742025A1 (en) * 1997-09-24 1999-03-25 Beiersdorf Ag Use of flavone or flavanone derivatives to treat or prevent undesirable skin pigmentation
DE19807774A1 (en) * 1998-02-24 1999-08-26 Beiersdorf Ag Use of flavone, flavanone or flavonoid compound for protection of ascorbic acid or ascorbyl compound against oxidation, especially in cosmetic and dermatological preparations,
US8507018B2 (en) * 1998-03-12 2013-08-13 Mars, Incorporated Products containing polyphenol(s) and L-arginine and methods of use thereof
RU2269268C2 (en) * 1998-03-12 2006-02-10 Марс, Инкорпорейтед Polyphenol(s) and l-arginine-containing products as stimulators for nitrogen oxide production
AU2004200273B2 (en) * 1998-03-12 2008-02-07 Mars, Incorporated Products Containing Polyphenol(s) and L-Arginine to stimulate nitric oxide production
US6805883B2 (en) 1998-03-12 2004-10-19 Mars, Incorporated Food products containing polyphenol(s) and L-arginine to stimulate nitric oxide
US6028088A (en) * 1998-10-30 2000-02-22 The University Of Mississippi Flavonoid derivatives
JP3702141B2 (en) * 2000-01-28 2005-10-05 一弘 永井 Rust preventive and method for producing the same
EP1136073A1 (en) * 2000-03-22 2001-09-26 N.V. Nutricia Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress
KR20010097477A (en) * 2000-04-24 2001-11-08 성재갑 Flavonoid CDK inhibitors having a new structure
KR20010097480A (en) * 2000-04-24 2001-11-08 성재갑 CDK inhibitors having a new structure
KR20010097481A (en) * 2000-04-24 2001-11-08 성재갑 CDK inhibitors having a new structure
JP2002087975A (en) * 2000-09-13 2002-03-27 Pias Arise Kk Agent for suppressing production of nitrogen monoxide and skin care preparation, cosmetic and quasi-drug formulating the same agent therein
DE10054341A1 (en) * 2000-11-02 2002-05-08 Beiersdorf Ag Flavone, flavanone and flavonoid compounds are used as active agents in production of cosmetic or dermatological formulations for prophylaxis and repair of damage to skin DNA
EP1247527A1 (en) * 2001-04-03 2002-10-09 Cognis France S.A. Cosmetic and/or pharmaceutical preparations containing extracts of the plant Litchi chinensis Sonn
CA2357053A1 (en) * 2001-09-04 2003-03-04 Unknown Effectiveness of a combination of antioxidant substances for the treatment of alzheimer's disease
US20030078186A1 (en) * 2001-10-18 2003-04-24 Christopher W. Denver Method and composition for the prevention of the auto-oxidation of flavors and fragrances
US20030147972A1 (en) * 2002-02-05 2003-08-07 Christopher W. Denver Method and composition for diminishing loss of color in flavors and fragrances
KR20030093890A (en) * 2002-06-05 2003-12-11 김희성 Propolis soap composition and process for preparing the same
EP1581058A4 (en) * 2002-10-23 2006-11-29 Citrus And Allied Essences Ltd Method and composition for the prevention of the auto-oxidation of flavors and fragrances
JP2004210743A (en) * 2003-01-08 2004-07-29 Nagase & Co Ltd Agent for promoting production of ceramide
KR100581215B1 (en) * 2003-11-18 2006-05-22 주식회사 태평양 Flavonoid-deposited polymer composite particles and a process for preparation of the same, and cosmetic compositions containing the same
FR2898808B1 (en) * 2006-03-27 2008-05-02 Biotechmarine Soc Par Actions "COSMETIC ACTIVE INGREDIENT COMPOSED OF ARGININE FERRULATE AND A MICROALGUE EXTRACT AND USES THEREOF".
US20100048737A1 (en) * 2006-09-19 2010-02-25 Basf Se Cosmetic preparations based on molecularly imprinted polymers
EP3158989A3 (en) 2017-02-01 2017-10-11 SanderStrothmann GmbH Cosmetic skin treatment composition

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6124522A (en) * 1984-07-13 1986-02-03 Kao Corp Inhibitor composition for formation of skin peroxylipid
JPS63218649A (en) * 1987-01-26 1988-09-12 ジャン モレル Antioxidant amino acid base substance and antioxidant
JPH035423A (en) * 1989-06-01 1991-01-11 Ichimaru Pharcos Co Ltd Lipid peroxide production-inhibiting agent containing flavonoid
JPH0393782A (en) * 1989-08-30 1991-04-18 Pacific Chem Ind Co Cell protective agent for protecting cell from activated oxygens and method of its preparation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904754A (en) * 1966-10-13 1975-09-09 Morelle Jean V Therapeutic compositions containing lipopoly (alpha-amino acids)
FR1603799A (en) * 1968-12-20 1971-05-24 Acyl methionic acids composns
US3624114A (en) * 1969-12-18 1971-11-30 Jean V Morelle Fatty acid amido-methionine products
LU77994A1 (en) * 1977-08-19 1979-05-23 Oreal TINCTORIAL COMPOSITIONS BASED ON OXIDIZING COLORANTS CONTAINING AN ALKANOIC ACID (2,5-DIHYDROXYPHENYL) OR ONE OF ITS SALTS AS AN ANTI-OXIDANT AND PROCESS OF PREPARATION
IT1201149B (en) * 1987-01-14 1989-01-27 Indena Spa BIOFLAVONOID COMPLEXES WITH PHOSPHOLIPIDS, THEIR PREPARATION, USE AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS
CH672048A5 (en) * 1987-09-16 1989-10-31 Nestle Sa
FR2634779B1 (en) * 1988-07-29 1994-05-27 Oreal NOVEL ANTI-OXIDIZING SYSTEM BASED ON A STABILIZED ASCORBYL ESTER, CONTAINING, AT LEAST ONE TOCOPHEROL OR A MIXTURE OF TOCOPHEROLS OR CAFEIC ACID OR A DERIVATIVE THEREOF, AT LEAST ONE COMPLEX AGENT AND AT LEAST ONE NON-THIOLE POLYPEPTIDE, AND COMPOSITIONS CONTAINING SUCH ANTI-OXIDIZING SYSTEM
FR2653336B1 (en) * 1989-10-20 1994-04-08 Oreal PHARMACEUTICAL COMPOSITION AND DEPIGMENTANT COSMETICS BASED ON CAFEIC ACID.
EP0500332B1 (en) * 1991-02-19 1998-05-27 National Food Research Institute Ministry Of Agriculture, Forestry And Fisheries Novel acylamino acid compounds and a method for their production

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6124522A (en) * 1984-07-13 1986-02-03 Kao Corp Inhibitor composition for formation of skin peroxylipid
JPS63218649A (en) * 1987-01-26 1988-09-12 ジャン モレル Antioxidant amino acid base substance and antioxidant
JPH035423A (en) * 1989-06-01 1991-01-11 Ichimaru Pharcos Co Ltd Lipid peroxide production-inhibiting agent containing flavonoid
JPH0393782A (en) * 1989-08-30 1991-04-18 Pacific Chem Ind Co Cell protective agent for protecting cell from activated oxygens and method of its preparation

Also Published As

Publication number Publication date
US5587171A (en) 1996-12-24
CA2108804C (en) 2000-03-07
CA2108804A1 (en) 1994-04-23
JPH0710739A (en) 1995-01-13
FR2697159A1 (en) 1994-04-29
US5431912A (en) 1995-07-11
ATE141500T1 (en) 1996-09-15
DE69304172T2 (en) 1997-03-06
ES2093385T3 (en) 1996-12-16
FR2697159B1 (en) 1995-01-13
EP0595694B1 (en) 1996-08-21
DE69304172D1 (en) 1996-09-26
EP0595694A1 (en) 1994-05-04

Similar Documents

Publication Publication Date Title
JP2774926B2 (en) Skin protection composition
US5023235A (en) Antioxidant system based on an ascorbyl ester in combination with a complexing agent and a thiol and to compositions containing the same
US5520905A (en) Cosmetic or dermatological preparation comprising delta-aminolevulinic acid content as an active ingredient
JP3522378B2 (en) Composition containing a photocatalytic metal oxide and tocopherol and its use in the cosmetics field, etc.
US6231877B1 (en) Cosmetic composition exploiting synergistic radical scavenging effects
US5352695A (en) Use of lysine pyrrolidone carboxylate and/or of arginine pyrrolidone carboxylate as an antoxidant substance in cosmetic or pharmaceutical compositions
US5114716A (en) Anti-oxidant system containing stabilized ascorbyl ester, tocopherol or cafeic acid or a derivative thereof, a complexing agent and a polypeptide, and compositions containing the anti-oxidant system
ES2670335T3 (en) Antioxidant composition
US20030095959A1 (en) Topical skin composition
KR930007911B1 (en) External preparations free of discoloration
JPH06227961A (en) Cosmetic or medical composition
EP1231886A1 (en) Topical skin composition
JP2552297B2 (en) Beautiful skin cosmetics
US5358752A (en) Skin care composition
US5552158A (en) Skin care composition
US20030138466A1 (en) Antioxidant dermatological composition
US6124274A (en) Use of ascorbyl 2&#39;-phosphates for stabilizing vitamin A and/or vitamin A derivatives in cosmetic and pharmaceutical preparations
JP2651191B2 (en) Sunscreen composition and method for its preparation
JP2552298B2 (en) Beautiful skin cosmetics
US5250513A (en) Antioxidant system based on a basic amino acid in combination with a tocopherol or derivative thereof and a nonthiolated polypeptide, and compositions containing the same
KR100347976B1 (en) Composition for topical application to the skin and/or its superficial body growths, comprising at least one compound comprising a phenyloxime ftagment
KR20010062535A (en) Cosmetic composition comprising n-ethyloxycarbonyl-4-amino-phenol and arbutin or its derivatives and/or ellagic acid or its derivatives
JPWO2022010683A5 (en)

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees